Literature DB >> 20949716

Patterns of infections among blood donors in a tertiary care centre: a retrospective study.

Gagandeep Kaur1, Sabita Basu, Ravneet Kaur, Paramjit Kaur, Shailja Garg.   

Abstract

BACKGROUND: Transfusion-transmitted infections continue to be a threat to safe transfusion practices. We analysed the prevalence and patterns of co-infections among voluntary and replacement donors.
METHODS: Blood donations collected over a 5-year period were studied for the type of donation (voluntary or replacement), number of seroreactive cases and the number, type and distribution of co-infections.
RESULTS: Of the 42 439 units of blood collected over a 5-year period, 19 118 (45%) were from voluntary and 23 321 (55%) from replacement donors. There were 1603 seroreactive cases (3.8%). These included 250 with HIV (0.6%), 734 with hepatitis B surface antigen (HBsAg; 1.7%), 337 with hepatitis C virus (HCV; 0.8%) and 282 (0.7%) with VDRL (Venereal Diseases Research Laboratory) reactivity. Twenty-three (0.05%) of these had > or = 2 seroreactive infections; 20 of these were in replacement donors and only 3 in voluntary donors and the difference was statistically significant (p < 0.005). Among HIV seropositive donors, there were 4 seroreactive for syphilis and 5 for HBsAg. Among HIV seronegative donors, 5 were seroreactive for HBsAg and VDRL, 4 for HCV and VDRL, and 2 for HBsAg and HCV. One person was seroreactive for HIV, HBsAg and VDRL. The multiple infection rate showed a decreasing trend over the years.
CONCLUSION: Multiple infections pose a small but definite risk to the recipients of blood products. Voluntary donations are safer as compared with replacement ones and need to be encouraged.

Entities:  

Mesh:

Year:  2010        PMID: 20949716

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  12 in total

Review 1.  Syphilis testing in blood donors: an update.

Authors:  Gagandeep Kaur; Paramjit Kaur
Journal:  Blood Transfus       Date:  2014-11-21       Impact factor: 3.443

2.  Profile of blood donors and reasons for deferral in coastal South India.

Authors:  B Unnikrishnan; P Rao; N Kumar; S Ganti; R Prasad; A Amarnath; B Reshmi; V Kaur; P Kesharwani; M Seetha; A Nautiyal; P Goel; P Aggarwal
Journal:  Australas Med J       Date:  2011-07-31

3.  Family/friend donors are not true voluntary donors.

Authors:  Rohit Jain; Gajendra Gupta
Journal:  Asian J Transfus Sci       Date:  2012-01

4.  Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatits C virus in blood donors of Jammu Province: A tertiary care centre experience.

Authors:  Meena Sidhu; Urvershi Kotwal; Raman Kapoor; Tilakraj Raina
Journal:  Asian J Transfus Sci       Date:  2013-07

5.  Trends in transfusion transmitted infections among replacement blood donors in karachi, pakistan.

Authors:  Syed Mohammad Irfan; Jamal Uddin; Hasan Abbas Zaheer; Sadia Sultan; Amjad Baig
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

6.  Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India.

Authors:  Shivaram Chandrashekar
Journal:  Asian J Transfus Sci       Date:  2014-01

7.  Seropositivity of HIV, Hepatitis B and C, and syphilis among blood donors: A retrospective study.

Authors:  Shweta Prasad; K R Uma Bai
Journal:  Asian J Transfus Sci       Date:  2014-01

Review 8.  Family donors are critical and legitimate in developing countries.

Authors:  Jean-Pierre Allain; Cees Th Smit Sibinga
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

9.  Transfusion transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India.

Authors:  Rupali Mandal; Krishnendu Mondal
Journal:  J Tradit Complement Med       Date:  2015-04-03

10.  Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (Two Case Reports).

Authors:  Xuejun Chen; Mingming Zhou; Botao Ning; Hua Song; Shilong Yang; Yongmin Tang
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.